EX-3.1
from 8-K
1 page
Amendment No. 2 to the Amended and Restated By-Laws of Juniper Pharmaceuticals, Inc. (The “Corporation”) Effective July 2, 2018 All of the Other Provisions of the Amended and Restated By-Laws Shall Remain in Full Force and Effect. ***** Adopted by Resolution of the Board of Directors of the Corporation, the 2nd Day of July, 2018 /S/ Alicia Secor Alicia Secor, President and Chief Executive Officer
12/34/56
EX-3
from SC 13G/A
1 page
<page> Page 11 of 11 Exhibit C Identification and Classification of Subsidiary Which Acquired Security Being Reported on by the Parent Holding Company Ssim, a Registered Investment Adviser, Acquired "Beneficial Ownership" of the Securities Being Reported on as a Result of Its Discretionary Authority to Acquire, Dispose and (With Respect to Certain of Such Securities) Vote the Securities Being Reported On. Under a Series of SEC No-Action Letters, Including the Letter Issued to Warren Buffet and Berkshire Hathaway, Inc. (Available December 18, 1987), Ssco and Strome Are Each Considered the Equivalent of a Parent Holding Company of Ssim and Are Therefore Eligible to Report Their Indirect Beneficial Ownership in Such Shares on Schedule 13g
12/34/56